HEPA

Hepion Pharmaceuticals

Delisted

HEPA was delisted on the 12th of May, 2025.

3 hedge funds and large institutions have $6.79M invested in Hepion Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
TCIM
1
TIAA CREF Investment Management
New York
$3.98M +$1.99M +1 +100%
TA
2
Teachers Advisors
New York
$1.1M +$1.1M +1 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$952K
Morgan Stanley
4
Morgan Stanley
New York
$249K -$304K
PFS
5
Prospera Financial Services
Texas
$186K -$215K
Geode Capital Management
6
Geode Capital Management
Massachusetts
$120K -$140
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$31K -$36K
Bank of New York Mellon
8
Bank of New York Mellon
New York
$30K -$34K
Barclays
9
Barclays
United Kingdom
$27K
Cambridge Investment Research Advisors
10
Cambridge Investment Research Advisors
Iowa
$22K -$28K
Northern Trust
11
Northern Trust
Illinois
$18K -$21K
Nomura Holdings
12
Nomura Holdings
Japan
$17K
LWM
13
LBA Wealth Management
Florida
$15K -$15K
BIT
14
BlackRock Institutional Trust
California
$11K -$13K
EWA
15
Exencial Wealth Advisors
Oklahoma
$10K
BA
16
BlackRock Advisors
Delaware
$6K -$7K
UBS Group
17
UBS Group
Switzerland
$5K
BFA
18
BlackRock Fund Advisors
California
$5K -$71K
Wells Fargo
19
Wells Fargo
California
$3K -$4K
S
20
SignatureFD
Georgia
$1K -$1K
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$1K -$1K
VIA
22
Vantage Investment Advisors
Pennsylvania
$1K -$1K
SBL
23
Sargent Bickham Lagudis
Colorado
$1K -$1K
AFM
24
Anson Funds Management
Texas
-$1.37M -2 Closed
BIM
25
BlackRock Investment Management
Delaware
-$6K